Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early terlipressin plus norepinephrine in septic shock
ChiCTR2400082897Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of terlipressin in septic shock and sepsis (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Change in norepinephrine dosage. Started Apr 2024; status: recruiting.
02
Drugs
terlipressin
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on ChiCTR2400082897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082897.